How to Buy Mersana Therapeutics Stock
Mersana Therapeutics Inc
Mersana Therapeutics, Inc. , a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need.
Mersana Therapeutics stock last closed at $3.37, up 6.31% from the previous day, and has decreased 28.45% in one year. It has underperformed other stocks in the Biotechnology industry by 0.07 percentage points. Mersana Therapeutics stock is currently +320.72% from its 52-week low of $0.80, and -64.97% from its 52-week high of $9.62.
As of May 1, 2024, there are 121.3M MRSN shares outstanding. The market value of MRSN is $408.79M. In the past 24 hours, 1.75M MRSN shares were traded.
How to Buy Mersana Therapeutics Stock
Wondering how to invest in Mersana Therapeutics stock? Here's how.
- Figure out where to buy Mersana Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you decide where to buy Mersana Therapeutics stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your method of payment and add your info.
- Research Mersana Therapeutics stock: The Mersana Therapeutics ticker symbol is MRSN. Is Mersana Therapeutics stock a good investment? Should you buy shares of MRSN? How do MRSN's underlying business fundamentals look? Do top analysts think Mersana Therapeutics is a good buy? Why has MRSN's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if MRSN is a good stock to buy).
- Make your MRSN buy order: Decide if you will purchase MRSN shares at the current market price or use a limit order to buy MRSN stock at a specific price.
- Get the latest news on your MRSN position: Create a watchlist to monitor your position in Mersana Therapeutics stock.
Step 1: Figure out where to buy Mersana Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy MRSN shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Tech to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you need to fill out some personal information so you are able to buy MRSN today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to start a new trading account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've filled out your info on one of the most highly reviewed stock trading apps, you need to deposit funds:
Watch this video walkthrough for more details depositing funds into your brokerage account.
Step 4: Research Mersana Therapeutics stock
Once you have chosen the best place to buy Mersana Therapeutics stock, it's important to evaluate their stock before you invest, so you can understand the risk as well as the upside.
Mersana Therapeutics Numbers
MRSN Due Diligence Checks
WallStreetZen was designed to help average investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on MRSN's stock page.
Is MRSN stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge MRSN's fair value.
Using relative valuations ratios:
- MRSN could be overvalued based on its P/B ratio of 11.08x, relative to Biotechnology industry P/B ratio of 6.02x
You can do more valuation analysis on MRSN's stock here.
MRSN Financial Health Overview
Signs that MRSN is financially healthy:
- There are more short-term assets than long-term liabilities on the MRSN balance sheet.
- There are more short-term assets than short-term liabilities on the MRSN balance sheet.
- Total MRSN debt is lower than 5 years ago, relative to shareholder equity.
- MRSN has cash burn of 171050000. It has sufficient cash and short-term investments to cover this for at least one year.
Signs that MRSN is not financially healthy:
- MRSN has $209.08M in cash and short term investments. This is not sufficient to cover its annual cash burn of $171.05M.
- MRSN has a relatively high debt to equity ratio of 5.13.
- MRSN profit margin has gone up by 3.02 percentage points in the past year, but the company is still unprofitable.
Is MRSN stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 6 Wall Street analysts who research MRSN, the consensus analyst rating on Mersana Therapeutics is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent MRSN Analyst Recommendations
Ashiq Mubarack, a top 45% analyst from Citigroup upgrades MRSN to a strong buy rating and raises their MRSN price target from $1.00 to $5.00, on Dec 4, 2023.
You can dig deeper into what analysts are projecting on the Mersana Therapeutics stock forecast page.
MRSN Technical Indicators
How are MRSN Revenues/Earnings doing?
Last year, MRSN revenue was $36.86M. Over the past 5 year, MRSN's revenue has grown by 28.32% per year. This was slower than the Biotechnology industry average of 28.49%.
Learn more about MRSN's earnings and revenue performance here.
Who is buying/selling MRSN?
Over the past year, executives and large shareholders at MRSN have sold more shares than they have bought.
Mohan Bala, SVP Chief Development Officer of MRSN, was the latest MRSN insider to sell. They sold $9,298.01 worth of MRSN shares on Jan 16, 2024.
Get more info about who owns MRSN shares here.
Does MRSN provide a stable income stream?
No, Mersana Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about MRSN
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your MRSN buy order
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally fine for most investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given price limit, use a limit order.
Hit the Open button and eToro will place your order.
If you require additional info about investing in stocks on eToro, click the how to video below:
Step 6: Get the latest news on your MRSN position
Now that you own some shares in MRSN, you'll want to keep up with your new investment.
Put MRSN on a watchlist to get notified of the latest news about your MRSN stock.
MRSN Feed
How to Buy Stock in Mersana Therapeutics
To summarize, here are the 6 steps for buying Mersana Therapeutics stock:
- Figure out where to buy Mersana Therapeutics stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Research Mersana Therapeutics stock
- Make your MRSN buy order
- Get the latest news on your MRSN position
If you require a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Mersana Therapeutics, create a watchlist on WallStreetZen today.
More Stock Buying Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.